Efficacy and safety of eltrombopag in the treatment of immune thrombocytopenia patients with hepatitis B virus infection: A prospective, multicenter, single arm, phase II trial

被引：0

作者：

Chen, Yunfei ^{[1
,2
]}

Xu, Yanmei ^{[1
,2
]}

Huang, Yueting ^{[3
]}

Sun, Ting ^{[1
,2
]}

Hu, Yuefen ^{[4
]}

Xue, Feng ^{[1
,2
]}

Peng, Xuanwei ^{[5
]}

Lai, Yinghui ^{[5
]}

Zhou, Zeping ^{[6
]}

Zhou, Hu ^{[7
]}

Zhou, Rongfu ^{[8
]}

Liu, Wei ^{[1
,2
]}

Liu, Xiaofan ^{[1
,2
]}

Dong, Huan ^{[1
,2
]}

Fu, Rongfeng ^{[1
,2
]}

Ju, Mankai ^{[1
,2
]}

Dai, Xinyue ^{[1
,2
]}

Li, Huiyuan ^{[1
,2
]}

Liu, Xiaonan ^{[1
,2
]}

Ma, Yueshen ^{[1
,2
]}

Song, Zhen ^{[1
,2
]}

Peng, Jun ^{[4
,10
]}

Yang, Renchi ^{[1
,2
,9
]}

Zhang, Lei ^{[1
,2
,9
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Tianjin Key Lab Gene Therapy Blood Dis, CAMS Key Lab Gene Therapy Blood Dis, State Key Lab Expt Hematol,Natl Clin Res Ctr Blood, Tianjin, Peoples R China

[2] Tianjin Inst Hlth Sci, Tianjin, Peoples R China

[3] Xiamen Univ, Affiliated Hosp 1, Dept Hematol, Xiamen, Fujian, Peoples R China

[4] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan, Peoples R China

[5] Guangxi Med Univ, Affiliated Hosp 2, Nanning, Peoples R China

[6] Kunming Med Univ, Affiliated Hosp 2, Kunming, Peoples R China

[7] Henan Canc Hosp, Zhengzhou, Peoples R China

[8] Nanjing Univ, Affiliated Nanjing Drum Tower Hosp, Med Sch, Nanjing, Peoples R China

[9] Chinese Acad Med Sci & Peking Union Med Coll, Tianjin Key Lab Gene Therapy Blood Dis, CAMS Key Lab Gene Therapy Blood Dis, State Key Lab Expt Hematol,Natl Clin Res Ctr Blood, Tianjin 30020, Peoples R China

[10] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250012, Peoples R China

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2024年 / 99卷 / 01期

基金：

中国国家自然科学基金;

关键词：

LONG-TERM;

D O I：

10.1002/ajh.27141

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E22 / E25

页数：4

共 50 条

[1] Efficacy and Safety of Eltrombopag in Chinese Patients with Chronic Immune Thrombocytopenia: Stage 2 Results from a Multicenter Phase III Study
Yang, Renchi
Liu Xiaofan
Li, Junmin
Hou, Ming
Jie, Jin
Huang, Meijuan
Yu, Ziqiang
Xu, Xiaojun
Zhang, Xiaohui
BLOOD, 2018, 132
[2] Efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia: stage 2 results from a multicenter phase III study
Liu, Xiaofan
Hou, Ming
Li, Junmin
Jin, Jie
Huang, Meijuan
Yu, Ziqiang
Xu, Xiaojun
Zhang, Xiaohui
Yang, Renchi
PLATELETS, 2022, 33 (01) : 82 - 88
[3] Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial
Chen, Yunfei
Xu, Yanmei
Chi, Ying
Sun, Ting
Gao, Yuchen
Dou, Xueqing
Han, Zhibo
Xue, Feng
Li, Huiyuan
Liu, Wei
Liu, Xiaofan
Dong, Huan
Fu, Rongfeng
Ju, Mankai
Dai, Xinyue
Wang, Wentian
Ma, Yueshen
Song, Zhen
Gu, Jundong
Gong, Wei
Yang, Renchi
Zhang, Lei
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
[4] Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia
Yang, Renchi
Li, Junmin
Jin, Jie
Huang, Meijuan
Yu, Ziqiang
Xu, Xiaojun
Zhang, Xiaohui
Hou, Ming
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (01) : 101 - 110
[5] Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma
Antonio Silvani
Irene De Simone
Vittorio Fregoni
Elena Biagioli
Enrico Marchioni
Manuela Caroli
Andrea Salmaggi
Andrea Pace
Valter Torri
Paola Gaviani
Erica Quaquarini
Giorgia Simonetti
Eliana Rulli
Maurizio D’Incalci
Journal of Neuro-Oncology, 2019, 142 : 455 - 462
[6] Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma
Silvani, Antonio
De Simone, Irene
Fregoni, Vittorio
Biagioli, Elena
Marchioni, Enrico
Caroli, Manuela
Salmaggi, Andrea
Pace, Andrea
Torri, Valter
Gaviani, Paola
Quaquarini, Erica
Simonetti, Giorgia
Rulli, Eliana
D'Incalci, Maurizio
Poli, Davide
Mariotti, Evelina
Caramia, Grazia
Gritti, Angela Pesenti
Pacchetti, Ilaria
Zucchetti, Massimo
Lanza, Annalisa
Basso, Gianpaolo
Bini, Paola
Berzero, Giulia
Diamanti, Luca
Di Cristofori, Andrea
Manzoni, Andrea
Lanfranchi, Giordano
Ardizzoia, Antonio
Villani, Veronica
JOURNAL OF NEURO-ONCOLOGY, 2019, 142 (03) : 455 - 462
[7] Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial
Chakraborty, Sajib
Alam, Saruar
Sayem, Mohammad
Sanyal, Mousumi
Das, Tonmoy
Saha, Piyal
Sayem, Mohammad D.
Byapari, Bartholomia Keya
Tabassum, Chowdhury Tamanna
Kabird, Ahmedul
Amin, Md Robed
Nabi, A. H. M. Nurun
ECLINICALMEDICINE, 2020, 29-30
[8] A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome
Suemori, Koichiro
Saijo, Masayuki
Yamanaka, Atsushi
Himeji, Daisuke
Kawamura, Masafumi
Haku, Takashi
Hidaka, Michihiro
Kamikokuryo, Chinatsu
Kakihana, Yasuyuki
Azuma, Taichi
Takenaka, Katsuto
Takahashi, Toru
Furumoto, Akitsugu
Ishimaru, Toshiyuki
Ishida, Masayuki
Kaneko, Masahiko
Kadowaki, Norimitsu
Ikeda, Kenichi
Sakabe, Shigetoshi
Taniguchi, Tomohiro
Ohge, Hiroki
Kurosu, Takeshi
Yoshikawa, Tomoki
Shimojima, Masayuki
Yasukawa, Masaki
PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (02): : 1 - 19
[9] Efficacy and Safety of Dapsone in Primary Immune Thrombocytopenia. Results of a Randomized, Placebo-Controlled Multicenter Trial and of a Single-Arm, Emulated Trial in the Prospective, Multicenter Carmen-France Registry
Larue, Marion
Moulis, Guillaume
Rueter, Manuela
Audia, Sylvain
Terriou, Louis
Viallard, Jean-Francois
Petesch, Brigitte Pan
Royer, Bruno
Bonnotte, Bernard
Galicier, Lionel
Lambotte, Olivier
Lefrere, Francois
Cheze, Stephane
Ebbo, Mikael
Wagner-Ballon, Orianne
Mahevas, Matthieu
Godeau, Bertrand
Michel, Marc
BLOOD, 2023, 142
[10] Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
Lai, Shuzhen
Li, Peijing
Liu, Xiaohui
Liu, Guihong
Xie, Tieming
Zhang, Xing
Wang, Xiaoxuan
Huang, Jing
Tang, Yiqiang
Liu, Zhigang
Shen, Guoping
Li, Chaoming
Lu, Fangxiao
Wang, Lei
Jiang, Fagui
Sun, Caixing
Chen, Yuanyuan
Chen, Ming
CANCER BIOLOGY & MEDICINE, 2024, 21 (05)

← 1 2 3 4 5 →